Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-23

FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pravastatin Sodium (generic) from Teva Pharmaceuticals USA, Inc. The approval confirms the continued availabilit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)